-
UPCOMING EVENTS
SMC attend The 8th Taiwan-Japan Pharmaceutical Seminar/Business Matching!
2022.08.17
We are pleased to announce that SMC Laboratories will be virtually attending the 8th Taiwan-Japan Pharmaceutical Seminar/Business Matching on September 2nd.
-
PUBLICATION
A study using liver samples from the STAM™ model published in PLOS ONE.
2022.08.10
SMC is proud to announce that Institut de Recherches Servier (FRA) has published the results of their study using our STAM™ model liver samples in PLOS ONE.
-
PUBLICATION
2022.08.03
Today, we are pleased to announce the acceptance of our abstract on our NASH-hepatocellular carcinoma (HCC) model at the International Congress of Endocrinology 2022 (ICE2022) 【Online】, which is to be held on August 25th and 28th.
-
NEWS RELEASE
July 28th is World Hepatitis Day!
2022.07.27
In recognition of July 28th being World Hepatitis Day, we here at SMC thought it might be a good idea to help everyone around the globe have a deeper understanding of hepatitis, so please read on if you would like to learn more.
-
PUBLICATION
Drug Efficacy Study in the STAM™ Model Published in Translational Oncology
2022.07.20
SMC is proud to announce that Kurume University (JPN) has published the results of their study using our STAM™ model in Translational Oncology.
-
UPCOMING EVENTS
SMC attend BIO One-on-One Partnering™ in Bio Asia Taiwan!
2022.07.13
We are pleased to announce that SMC Laboratories will be virtually attending the BIO One-on-One PartneringTM in Bio Asia Taiwan from July 27th to 31th.
-
UPCOMING EVENTS
2022.07.06
Today, we are pleased to announce the acceptance of our abstract on our NASH-hepatocellular carcinoma (HCC) model at the 29th convention of The Japanese Society for the Research of Hepatic Cells, which is to be held on August 25th and 26th.
-
PUBLICATION
GN Corporation publication in Journal of Clinical and Experimental Hepatology
2022.06.30
SMC announces that GN Corporation Clinical and Experimental Hepatology (Japan) has published the results of a study using STAM™ mouse model in Clinical and Experimental Hepatology.
-
PUBLICATION
Esperion Therapeutics's publication in Cell Metabolism
2022.06.21
SMC announces that Esperion Therapeutics (MI, USA) has published the results of a study using STAM™ mouse model in Cell Metabolism.
-
PRODUCTS AND SERVICES
Potential NASH biomarker in NASH-HCC model
2022.06.10
We would like to introduce the data for a serological marker from our NASH model (STAM™ model).
-
PUBLICATION
Drug efficacy studies in NASH mouse model
2022.05.23
We would like to introduce a study published by our client using our proprietary non-alcoholic steatohepatitis (NASH) model called STAM™ (Ikewaki et al., bioRxiv, 2021).
-
PRODUCTS AND SERVICES
Introducing our new model: DDC-induced liver injury model
2022.05.10
We introduce the 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced liver injury model*, a well-known model of cholestatic liver disease and a new model we have started offering our services as.